Who owns Ascend Advanced Therapies?

Ascend Advanced Therapies is currently owned by 4Bio Partners, through 4BIO Ventures III, since 2023.

When did 4Bio Partners acquire Ascend Advanced Therapies?

4Bio Partners acquired Ascend Advanced Therapies in 2023 (active for 3 years).

Home/Companies/Biotech/Ascend Advanced Therapies

Ascend Advanced Therapies

Biotech·

UK·Active·3yr hold

Ascend Advanced Therapies is a biotech company, headquartered in UK.

Entry

2023

Hold

3yr

Status

Active

Est. EV

–

Investor

4Bio Partners

Key facts

HQUK

SectorBiotech

StatusActive

Gene and cell therapy manufacturing specialist; 4BIO Capital participated in its 2023 launch Series A financing.

See the full ownership history.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Full fund context: vintage, strategy, region

Start free

Already a member? Sign in

More from 4BIO Ventures III

Other portfolio companies in the same fund.

Cytospire Therapeutics

More PE-backed in Biotech

Comparable biotech deals from other GPs.

AdBio PartnersBelgium

Last updated May 2026 · Sourced from public filings